None listed
Conditions
Interventions
Medical Device : After randomization, subjects allocated to the CGM group, subjects were managed according to the results of the CGM system, and followed up the CGM system at 3 months. Cardiac ultraso
Sponsors
The Catholic University of Korea, St. Vincent's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Patients with type 2 diabetes using insulin or insulin + oral hypoglycemic agents - Men and women aged 19 to 75 years old - >= 7.5% HbA1c at baseline - A person who can measure his or her own blood glucose. - A person who agrees to participate in this clinical trial and agrees in writing consent.
Exclusion criteria
Exclusion criteria: - Type 1 diabetes. - Patients with severe renal insufficiency: eGFR < 30 ml/min - Those who have been diagnosed with a previous coronary artery disease, cardiovascular surgery or stroke - Person diagnosed with previous heart failure - Person who has been diagnosed with a malignancy within the last five years and whose treatment has not been completed. - Recipients of organ transplantation or long-term immunosuppressants - Steroid user - Pregnant or breastfeeding women - A person who is deemed unfit to participate in a clinical trial by investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of E/e' changes compared to control group | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of change in glycemic variability compared to control group;Comparison of change in HbA1c compared to control group;Comparison of development or progression of diabetic retinopathy compared to control group;Comparison of change in urine albumin-to-creatinine ratio compared to control group;Comparison of change in severe hypoglycemia compared to control group | — |
Countries
Korea, Republic of
Contacts
Public ContactSeon-Ah Cha
The Catholic University of Korea, St. Vincent's Hospital
Outcome results
None listed